Search Results - "Cavalot, F."

Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes by Cavalot, F.

“…In recent years glycaemic variability (GV) has emerged as a determinant of vascular complications of both type 1 and type 2 diabetes mellitus. In type 1…”
Get full text

Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study by Cavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., Trovati, M.

“…Objective: The influence of postprandial blood glucose on diabetes complications is intensively debated. We aimed to evaluate the predictive role of both…”
Get full text

Daily glycaemic variability: benefits of optimal control by Cavalot, F.

Get full text

How can we monitor glycaemic variability in the clinical setting? by Inchiostro, S., Candido, R., Cavalot, F.

“…No universal consensus exists on how to express glycaemic variability. Among other parameters, standard deviation of blood glucose values, mean amplitude of…”
Get full text

In Type 2 Diabetes mellitus the GLP-1 effects on platelets are impaired by Barale, C, Frascaroli, C, Cavalot, F, Guerrasio, A, Russo, I

Get full text

Outcomes of integrated management versus specialized care for patients with type 2 diabetes: An observational study by Sabione, I., Cavalot, F., Paccotti, P., Massucco, P., Vigna-Taglianti, F.D.

“…To compare type 2 diabetes (T2D) patients included in a Diabetes Integrated Management (DIM) program with those followed in Diabetes Specialized Care (DSC),…”
Get full text

Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: Results from the MIND.IT Study Group of the Italian Society of Diabetology by Franzini, L, Ardigò, D, Cavalot, F, Miccoli, R, Rivellese, A.A, Trovati, M, Zavaroni, I, Vaccaro, O

“…Abstract Background and aims The study explores the degree of control of hyperglycaemia and cardiovascular (CV) disease risk factors in men and women with type…”
Get full text

The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy by Vaccaro, O, Boemi, M, Cavalot, F, De Feo, P, Miccoli, R, Patti, L, Rivellese, A.A, Trovati, M, Ardigò, D, Zavaroni, I

“…Abstract Introduction and aim Guidelines for cardiovascular prevention in diabetes have been issued by the national and international scientific societies. No…”
Get full text

Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations by Rivellese, A.A, Boemi, M, Cavalot, F, Costagliola, L, De Feo, P, Miccoli, R, Patti, L, Trovati, M, Vaccaro, O, Zavaroni, I

“…Objective: To clarify adherence of type II diabetic patients to dietary recommendations. Subjects and methods: The dietary habits of a group of 540 patients,…”
Get full text

Effects of a 8-week treatment with monoclonal antibody anti-PCSK9 therapy on platelet function in subjects affected by familial hypercholesterolemia by Barale, C, Bonomo, K, Noto, F, Traversa, M, Cavalot, F, Iozzia, M.D, Frascaroli, C, Guerrasio, A, Russo, I

Get full text

Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study by Bianchi, C, Miccoli, R, Bonadonna, R.C, Giorgino, F, Frontoni, S, Faloia, E, Marchesini, G, Dolci, M.A, Alviggi, L, Gnasso, A, Consoli, A, Cavalot, F, Cavallo, M.G, Leonetti, F, Giaccari, A, Del Prato, S

“…Abstract Background and Aim We evaluated the relationship between insulin resistance (IR) and insulin secretion with the metabolic syndrome (MS) in 885…”
Get full text

Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate by Trovati, M., Anfossi, G., Massucco, P., Mattiello, L., Costamagna, C., Piretto, V., Mularoni, E., Cavalot, F., Bosia, A., Ghigo, D.

“…Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic…”
Get full text

Clinical application of best practice guidelines for the genetic diagnosis of MODY2 and MODY3 by Incani, M., Cambuli, V. M., Cavalot, F., Congiu, T., Paderi, M., Sentinelli, F., Romeo, S., Poy, P., Soro, M., Pilia, S., Loche, S., Cossu, E., Trovati, M., Mariotti, S., Baroni, M. G.

Get full text

N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets by Anfossi, G., Russo, I., Massucco, P., Mattiello, L., Cavalot, F., Trovati, M.

“…Background N‐acetyl‐l‐cysteine, a thiol compound, has been shown to potentiate the inhibition of platelet aggregation exerted by organic nitrates and to…”
Get full text

Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM by Anfossi, G. (University of Turin, Orbassano, Turin, Italy.), Mularoni, E.M, Burzacca, S, Ponziani, M.C, Massucco, P, Mattiello, L, Cavalot, F, Trovati, M

“…Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. G Anfossi , E M…”
Get full text

Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3' :5'-cyclic monophosphate and adenosine 3' :5'-cyclic monophosphate concentrations by TROVATI, M, MASSUCCO, P, MATTIELLO, L, COSTAMAGNA, C, ALDIERI, E, CAVALOT, F, ANFOSSI, G, BOSIA, A, GHIGO, D

“…Insulin incubation of human vascular smooth muscle cells (hVSMC) for 120 min increases both guanosine 3':5'-cyclic monophosphate (cGMP) and adenosine…”
Get full text

Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients by Trovati, M., Mularoni, E. M., Burzacca, S., Ponziani, M. C., Massucco, P., Mattiello, L., Piretto, V., Cavalot, F., Anfossi, G.

“…Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. M Trovati , E M Mularoni , S Burzacca , M C Ponziani , P…”
Get full text

Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect by Trovati, M., Massucco, P., Mattiello, L., Mularoni, E., Cavalot, F., Anfossi, G.

“…Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. M Trovati , P Massucco…”
Get full text

Insulin increases cyclic nucleotide content in human vascular smooth muscle cells : a mechanism potentially involved in insulin-induced modulation of vascular tone by TROVATI, M, MASSUCCO, P, MATTIELLO, L, CAVALOT, F, MULARONI, E, HAHN, A, ANFOSSI, G

“…It has been suggested that insulin exerts a vasodilating effect, but the mechanisms involved are not completely understood. Since cyclic nucleotides mediate…”
Get full text

The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide by Trovati, M., Massucco, P., Mattiello, L., Piretto, V., Cavalot, F., Mularoni, E., Anfossi, G.

“…The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide. M Trovati , P Massucco , L Mattiello , V…”
Get full text